Latest news with #UNH
Yahoo
2 days ago
- Business
- Yahoo
Trump's approval rating in NH has declined amid Qatar jet, Ukraine conflict, says new poll
President Donald Trump's approval rating in New Hampshire has declined in the last month, as most Granite Staters disapprove of Trump's plan to accept a jet from Qatar and want the US to be more supportive of Ukraine, reveals a new poll from University of New Hampshire Survey Center. Per the poll, 55% of New Hampshire residents disapprove of Trump's handling of his job as president while 45% approve, giving him a net approval rating of -10. His approval has decreased since April, when the UNH poll found his approval at -6. His approval among NH Republicans is 93%, down since it hit a record high in April of 96%. His approval among Independents has also dropped, from 51% to 35%. Just 1% of Democrats approve. The poll, released May 29, also looked at approval of Trump's handling of the economy and foreign affairs. As the U.S. economy continues to feel the effects of Trump's on-again, off-again tariffs, 54% of Granite Staters disapprove of his handling of the economy, while 45% approve. 54% also disapprove of his handling of foreign policy. Trump announced earlier in May that he will accept the gift of a luxury jet from Qatar to be used as Air Force One and then donated to his presidential library at the end of his term in office. Sen. Jeanne Shaheen, D-NH, said that the act 'raises serious constitutional and ethical questions.' The poll found that 61% of New Hampshire residents agree with Shaheen and believe that it's inappropriate for Trump to receive the plane. Granite Staters also think that the U.S. is doing too little to support Ukraine in the war with Russia. Per the poll, 46% think this, up from 34% who thought that in March. 24% think that the U.S. is supporting Ukraine the right amount, and 15% think the U.S. should not be aiding Ukraine at all. While his approval might be dropping in New Hampshire, Trump's national approval rating has remained steady over the past month. An average of recent polls from the New York Times shows that his approval rating as of May 30 is 45%, with 52% disapproving of his performance. This has remained virtually unchanged over the past month since his approval bounced back after a second term low in the last week of April. Here's what some of the most current polls show about Trump's presidential job approval rating as of May 30. YouGov/Economist: Disapprove +8 (44% approve, 52% disapprove) Poll taken May 23-26 1,660 adultsDisapprove +3 (48% approve, 51% disapprove) Poll taken May 23-25 2,237 registered voters : Disapprove +14 (41% approve, 55% disapprove) Poll taken May 17-20 1,100 adults : Disapprove +10 (42% approve, 52% disapprove) Poll taken May 16-18 1,024 adults : Disapprove +10 (43% approve, 53% disapprove) Poll taken May 1-18 1,003 adults This article originally appeared on The Providence Journal: President Trump approval rating in NH: Latest poll reveals decline
CNBC
2 days ago
- Business
- CNBC
Deutsche Bank says take chance on beaten-up UnitedHealth because of valuation
UnitedHealth could be a bargain for investors, according to Deutsche Bank. Analyst George Hill maintained his buy rating along with his target price of $362. That, he said, reflects an earnings multiple of 16 — which sits at the low end of the stock's 10-year trading range. Hill's forecast implies UnitedHealth shares could gain 21.4% from Thursday's close. "We're hanging our gloves on valuation: We maintain our buy rating on UNH's shares, as even here using a trough-ish multiple on our expected 2025 trough earnings still implies meaningful upside to the shares," Hill said in a Thursday note to clients. "We continue to see the company as a defensive name in the large-cap healthcare services space, though UNH has been burdened by a rotating array of headwinds over the last several years," he added. UnitedHealth shares have suffered a 41% decline this year as the company deals with multiple setbacks, including the recent exit of its CEO , suspension of its annual forecast, reports of a Department of Justice investigation into fraud allegations and higher medical costs. "Our target multiple reflects the continued challenges, regulatory overhang, and persistent negative sentiment tied to the MCO space," Hill said. UNH 1Y mountain UnitedHealth 1-yr chart Hill thinks there's plenty of upside ahead for UnitedHealth, but said the company should ditch its current long-term guidance, which sits higher than the range of most other managed care companies. He expects the company's core managed care business to generate operating profit growth of between 3% and 5% as Medicare Advantage plans mature. The company's ability to grow its operating profit growth through acquisition will be "challenged at best," according to the analyst. He added that there also remains an ongoing regulatory overhang on the company and negative sentiment in the managed care space.
Boston Globe
2 days ago
- Politics
- Boston Globe
New poll shows R.I. Governor Dan McKee's approval rating at 19 percent
The bigger picture: McKee announced plans to Get Rhode Map A weekday briefing from veteran Rhode Island reporters, focused on the things that matter most in the Ocean State. Enter Email Sign Up So what now? Advertisement If you're Foulkes, you do you. You keep raising money, and you cross your fingers that McKee stays in the race and any other top tier contenders take a pass. If you're Shekarchi, this is when you ramp up behind-the-scenes talks with union leaders to suggest that it's time to nudge McKee into retirement with the old 'for the good of the Democratic Party' argument. Translation: Your point is, 'If you don't want Foulkes, you need me.' Advertisement If you're Neronha, you capitalize on your moment. Your But campaigns don't magically come together, so you have to start raising money and building a team. If you're McKee, you brace yourself and buckle in. You and your team have always known this campaign was going to be a slog. Yes, but: The poll asks relatively generic questions that offer voters the ability to vent their frustrations, but it doesn't demonstrate the decision they'll have to make between the candidates, which McKee has consistently won during three successful campaigns for statewide office in the past. Still, McKee is in desperate need of a UNH poll shows President Trump's job approval at 37 percent – nearly twice McKee's. He might get a boost in the next week or so because This story first appeared in Rhode Map, our free newsletter about Rhode Island that also contains information about local events, links to interesting stories, and more. If you'd like to receive it via e-mail Monday through Friday, Dan McGowan can be reached at
Yahoo
2 days ago
- Business
- Yahoo
UnitedHealth Group Incorporated (UNH): A Bull Case Theory
We came across a bullish thesis on UnitedHealth Group Incorporated (UNH) on FluentInQuality's Substack. In this article, we will summarize the bulls' thesis on UNH. UnitedHealth Group Incorporated (UNH)'s share was trading at $295 as of 27th May. UNH's trailing and forward P/E were 12.35 and 12.92 respectively according to Yahoo Finance. alexkich/ UnitedHealth Group is well-positioned as Medicare Advantage grows, with its Optum Health division reaching nearly 100 million consumers annually, reflecting massive scale but showing recent stagnation likely due to market saturation, post-pandemic shifts, and a focus on value-based care. Leadership changes saw the return of former CEO Stephen Hemsley, whose long tenure and deep involvement have driven significant company growth, now reinforced by a substantial equity stake that aligns his interests with shareholders. Employee sentiment, based on thousands of Indeed reviews, is generally positive, highlighting competitive pay, mission alignment, career growth opportunities, and work-life balance, though communication from management could improve. UnitedHealth's financial performance shows strong value creation, with return metrics at the high end for healthcare insurers despite the capital-intensive nature of the industry. Insider and institutional ownership indicate confidence, with major executives and directors holding meaningful stock positions and many institutions increasing their shares. The company's competitive advantages stem from its unmatched scale, extensive provider network, and vertical integration via Optum, which spans insurance, care delivery, pharmacy benefits, and data analytics, creating high switching costs and operational efficiencies. Although its brand faces some reputational challenges, UnitedHealth leverages its vast network and embedded contracts to maintain pricing power and market dominance. The healthcare industry itself is on a robust growth trajectory, with U.S. spending projected to rise from $4.5 trillion in 2024 to $6.8 trillion by 2032, driven by aging demographics, chronic disease, and increased managed care adoption, providing strong secular tailwinds for UnitedHealth's continued expansion and innovation. Previously, we have covered UnitedHealth Group Incorporated (UNH) in April 2025, wherein we summarized a bullish thesis by Oguz Erkan on Substack. The author highlighted its position as a resilient healthcare compounder, benefiting from the defensive nature of health insurance and strong pricing power even during economic downturns. Despite recent challenges and skepticism, UNH's vertically integrated model through Optum supported consistent revenue growth of 11% annually, with a fair valuation reflected in its forward P/E of 20, making it an attractive long-term investment, especially on price dips below $550. UnitedHealth Group Incorporated (UNH) is on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 139 hedge fund portfolios held UNH at the end of the first quarter which was 150 in the previous quarter. While we acknowledge the risk and potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than UNH but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
UnitedHealth Group Incorporated (UNH): A Bull Case Theory
We came across a bullish thesis on UnitedHealth Group Incorporated (UNH) on FluentInQuality's Substack. In this article, we will summarize the bulls' thesis on UNH. UnitedHealth Group Incorporated (UNH)'s share was trading at $295 as of 27th May. UNH's trailing and forward P/E were 12.35 and 12.92 respectively according to Yahoo Finance. alexkich/ UnitedHealth Group is well-positioned as Medicare Advantage grows, with its Optum Health division reaching nearly 100 million consumers annually, reflecting massive scale but showing recent stagnation likely due to market saturation, post-pandemic shifts, and a focus on value-based care. Leadership changes saw the return of former CEO Stephen Hemsley, whose long tenure and deep involvement have driven significant company growth, now reinforced by a substantial equity stake that aligns his interests with shareholders. Employee sentiment, based on thousands of Indeed reviews, is generally positive, highlighting competitive pay, mission alignment, career growth opportunities, and work-life balance, though communication from management could improve. UnitedHealth's financial performance shows strong value creation, with return metrics at the high end for healthcare insurers despite the capital-intensive nature of the industry. Insider and institutional ownership indicate confidence, with major executives and directors holding meaningful stock positions and many institutions increasing their shares. The company's competitive advantages stem from its unmatched scale, extensive provider network, and vertical integration via Optum, which spans insurance, care delivery, pharmacy benefits, and data analytics, creating high switching costs and operational efficiencies. Although its brand faces some reputational challenges, UnitedHealth leverages its vast network and embedded contracts to maintain pricing power and market dominance. The healthcare industry itself is on a robust growth trajectory, with U.S. spending projected to rise from $4.5 trillion in 2024 to $6.8 trillion by 2032, driven by aging demographics, chronic disease, and increased managed care adoption, providing strong secular tailwinds for UnitedHealth's continued expansion and innovation. Previously, we have covered UnitedHealth Group Incorporated (UNH) in April 2025, wherein we summarized a bullish thesis by Oguz Erkan on Substack. The author highlighted its position as a resilient healthcare compounder, benefiting from the defensive nature of health insurance and strong pricing power even during economic downturns. Despite recent challenges and skepticism, UNH's vertically integrated model through Optum supported consistent revenue growth of 11% annually, with a fair valuation reflected in its forward P/E of 20, making it an attractive long-term investment, especially on price dips below $550. UnitedHealth Group Incorporated (UNH) is on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 139 hedge fund portfolios held UNH at the end of the first quarter which was 150 in the previous quarter. While we acknowledge the risk and potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than UNH but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
